Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Davi II - Farmacêutica is a Portuguese pharmaceutical company specializing in the import, marketing, and distribution of healthcare products, with a primary focus on ophthalmology and otorhinolaryngology (ENT). Founded in 2007 and based in Barcarena, the company provides a range of specialized solutions including eye drops, hygiene wipes, and hospital equipment. Formerly a subsidiary of the global CDMO Recipharm, Davi II was acquired by Pihex Investimentos in 2020. The company serves the Portuguese market and maintains an international presence in regions such as the Middle East. Its portfolio includes well-known brands like Alergiftalmina and Blefarix, catering to both clinical and consumer health needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DAVI II - Farmacêutica.